Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Psychedelics Research Recent news which mentions Psychedelics Research Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences April 29, 2024 Tickers NEWS Tags Psychedelics Research Psychedelics Psychology From Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Tickers AWKNF BETRF CMND FLHLF Tags HUGE Psychedelics Reform Psychedelics Research From Benzinga Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Tickers AGNPF ATAI CMND CMPS Tags Benzinga Psychedelics Podcast MNMD ATAI From Benzinga Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends April 15, 2024 Tickers NEWS NUMIF Tags financial results Psychedelic/Assisted Therapies Benzinga From Benzinga Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute April 09, 2024 Tickers NEWS OPTHF Tags Psychedelics OPTHF Contracts From Benzinga Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More April 05, 2024 Tags Market News Cannabis Global From Benzinga DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design April 03, 2024 Tickers AGNPF Tags Management Psychedelics Psychedelics Research From Benzinga Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Tickers CMND CMPS CYBN FLHLF Tags Psychedelic/Assisted Therapies Benzinga SILO From Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Tickers ATAI CMND CMPS DRUG Tags Elon Musk TSLA Benzinga From Benzinga Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline March 29, 2024 Tickers ATAI CMPS Tags CMPS Psychedelics Research ATAI From Benzinga Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression March 28, 2024 Tickers ATAI NEWS Tags ATAI Psychedelics Research News From Benzinga PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development March 27, 2024 Tickers MDXXF Tags Psychedelics Research Psychedelics Legal From Benzinga Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Tickers MDXXF NEWS NUMIF OPTHF Tags Addiction Treatment Management Psychedelics Research From Benzinga Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions March 25, 2024 Tickers NEWS NUMIF Tags News MDMA Therapy Psychedelics Research From Benzinga Congress Discusses Remaining FY2024 Spending Bill With Provisions On Cannabis Sales And Psychedelic Clinical Trials March 22, 2024 Tags Market News B/C/ cannabis Cannabis From Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Tickers ATAI CMND CMPS CYBN Tags GHRS Psychedelic/Assisted Therapies Benzinga From Benzinga Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Tickers ATAI BETRF CMND ENVB Tags OPTHF Biotech CMND From Benzinga Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Tickers ATAI CMND CMPS CYBN Tags Legal ATAI MNMD From Benzinga Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More March 01, 2024 Tickers BRAXF FLHLF OPTHF SILFF Tags Events SILFF OPTHF From Benzinga Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights February 29, 2024 Tags Psychedelic/Assisted Therapies American Psychedelic Practitioners Association Benzinga From Benzinga Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety February 28, 2024 Tickers IXHL NEWS Tags Benzinga Cannabis Market News From Benzinga FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 January 31, 2024 Tickers JNJ MNMD Tags Reagan/Udall Foundation for the FDA Biotech Events From Benzinga Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Tickers AWKNF CMND CMPS FLHLF Tags Regulations Psychedelics Research CMPS From Benzinga Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More January 15, 2024 Tickers ATAI CMND CMPS CYBN Tags Markets News Psychedelics Reform From Benzinga DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases November 01, 2023 Tags News Delta/9 THC Psychedelics From Benzinga Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents October 26, 2023 Tickers CYBN DMTTF Tags Psychedelics Contracts Penny Stocks From Benzinga Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics October 23, 2023 Tickers CYBN DMTTF Tags Psychedelics M&A CYBN From Benzinga Harvard's New Psychedelics Research Program Backed By Former Tesla Director's $16M Donation October 18, 2023 Tickers NFLX TSLA Tags Psychedelics Research General Harvard University From Benzinga Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Passes Away At Age 77 October 18, 2023 Tags Psychedelics Research General Psychedelics From Benzinga Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News September 15, 2023 Tickers NUMIF Tags Cannabis Market News NUMIF From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.